LinkedIn Content Strategy & Writing Style
CEO at Ritholtz Wealth Management
0 people tracking this creator on ViralBrain
Joshua Brown positions himself as the quintessential cultural bridge between Wall Street and Main Street, blending institutional authority with a street-smart, conversational skepticism. His content strategy centers on identifying "value traps" and "halo businesses" while using humor and satire to demystify complex private equity and venture secondary markets. He is notable for his ability to translate high-level macro shifts into relatable narratives, often using a New York-centric vernacular to critique industry absurdity. By intersecting wealth management leadership with a media-heavy approach to product launches, Brown creates a unique "finance rock star" persona that prioritizes narrative-driven insights over dry technical analysis.
0
0
690
6.8
1
25 years ago, Blockbuster, RadioShack, McClatchy and Borders began to sell off due to potential disruption risk from Amazon, Netflix and Google. My brilliant friend Kai Wu demonstrates that while thei…
Hi I’ll have bacon egg and cheese on a roll. You got it. We all also have access to SpaceX shares. No thanks, just the sandwich. Deli Ventures SPV has an established track record in venture seco…
Sean Barrett says Toast (TOST) could be a 10x. I say at least 5x. This is a HALO business where all 170,000 customers (restaurant locations) are using the HARDWARE so that the software can run their b…
The stars were OUT for the Porterhouse strategy launch party in New York City! See how many of your favorite finance rock stars you can recognize. If you know them all, you're a true market player 🤩…
6.8 posts/week
Posts / Week
1.2 days
Days Between Posts
1
Total Posts Analyzed
HIGH
Posting Frequency
689.875%
Avg Engagement Rate
STABLE
Performance Trend
450
Avg Length (Words)
HIGH
Depth Level
ADVANCED
Expertise Level
0.95/10
Uniqueness Score
YES
Question Usage
0.85%
Response Rate
Writing style breakdown
<start of post>
The stock market is currently obsessed with 'efficiency' but they are missing the forest for the trees.
I sat down with Sarah Jenkins to discuss why the next decade of biotech belongs to the 'platform' companies rather than the single-drug wonders. Most investors are looking at clinical trial dates. The smart money is looking at the underlying data architecture that allows these trials to happen in half the time.
The best part is the valuation gap between these two groups is the widest it has been since 2001. If you aren't looking at the software layer of healthcare, you're flying blind.
the full conversation is live on the podcast now, don't miss it.
https://lnkd.in/eXample123
<end of post>
Sign in to unlock the full writing analysis
Free tools to help you write, score, and benchmark in the same style.
Other creators worth studying alongside Joshua Brown.
14 Viral Score
Eric Blaauboer
Schrijver van "Je Laatste: stoppen met roken, op weg naar nicotinix"
53 Viral Score
12 Viral Score
38 Viral Score
Marina Mogilko
Helping ambitious people worldwide go from passion to profit | 18M+ community, built two 8-figure businesses
51 Viral Score
Denys Kliuch
CEO at Whimsy Games | Expert in Game Development | Web3 Enthusiast | Forbes Council Member | Open to Collaborate
27 Viral Score
ViralBrain plans, writes, and schedules your LinkedIn content, using official LinkedIn APIs so your account stays safe.
Write like Joshua Brown.
